General Archive
-
Breast cancer: new treatment monitoring test avoids risks from biopsy
Through their shared dedication to patients, LifeArc and diagnostics company Biocartis are developing a ‘liquid biopsy’ test for breast cancer…
-
Renishaw Diagnostics: a test for antibiotic resistance
We collaborated with Renishaw Diagnostics Ltd. on a rapid diagnostic test for the detection of carbapenemase genes, which are associated…
-
News releases
TYSABRI gains market approval
Biogen Idec and Elan Corporation yesterday announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food…
-
News releasesTherapeutic Antibody Group starts
The Therapeutic Antibody Group (TAG) will comprise former AERES scientists. As part of MRCT’s evolving strategy of adding significant value…